Spikevax is a Intramuscular Injection, Suspension in the Vaccine category. It is labeled and distributed by Moderna Us, Inc.. The primary component is Elasomeran.
| Product ID | 80777-100_8483facf-1d72-4de3-ac81-eedc517bac1b |
| NDC | 80777-100 |
| Product Type | Vaccine |
| Proprietary Name | Spikevax |
| Generic Name | Covid-19 Vaccine, Mrna |
| Dosage Form | Injection, Suspension |
| Route of Administration | INTRAMUSCULAR |
| Marketing Start Date | 2022-04-01 |
| Marketing Category | BLA / |
| Application Number | BLA125752 |
| Labeler Name | Moderna US, Inc. |
| Substance Name | ELASOMERAN |
| Active Ingredient Strength | 0 mg/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-04-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 61434-043 | SPIKEVAX | COVID-19 Vaccine, mRNA |
| 80777-100 | Spikevax | COVID-19 Vaccine, mRNA |
| 0069-2025 | Comirnaty | COVID-19 Vaccine, mRNA |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() SPIKEVAX 97037862 not registered Live/Pending |
ModernaTx, Inc. 2021-09-21 |
![]() SPIKEVAX 90247367 not registered Live/Pending |
ModernaTx, Inc. 2020-10-11 |